David Gur Selected Research

Ciprofloxacin (Cipro)

1/2021	Screening of an FDA-Approved Library for Novel Drugs against Y. pestis.
11/2020	Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Gur Research Topics

Disease

18	Plague (Bubonic Plague) 01/2022 - 02/2004
16	Infections 04/2022 - 05/2015
6	COVID-19 11/2021 - 01/2021
4	Neoplasms (Cancer) 12/2019 - 05/2005
3	Disease Progression 10/2020 - 01/2013
3	Chronic Obstructive Pulmonary Disease (COPD) 05/2014 - 08/2009
3	Emphysema 04/2011 - 08/2004
2	Virus Diseases (Viral Diseases) 01/2021 - 11/2020
2	Breast Neoplasms (Breast Cancer) 12/2019 - 05/2014
1	Acute Lung Injury 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Human Influenza (Influenza) 11/2020
1	Anthrax 01/2018
1	Tularemia 01/2018
1	Cystic Fibrosis (Mucoviscidosis) 01/2018
1	Chronic Bronchitis 01/2014
1	Bacterial Infections (Bacterial Infection) 01/2012
1	Metabolic Bone Diseases (Osteopenia) 04/2011
1	Osteoporosis 04/2011
1	Thyroid Nodule (Nodule, Thyroid) 08/2009

Drug/Important Bio-Agent (IBA)

9	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2007
6	VaccinesIBA 01/2021 - 09/2009
4	Neutralizing AntibodiesIBA 04/2022 - 05/2021
4	Monoclonal AntibodiesIBA 11/2021 - 01/2021
4	Proteins (Proteins, Gene)FDA Link 03/2021 - 08/2009
3	Biomarkers (Surrogate Marker)IBA 03/2021 - 08/2009
3	AntigensIBA 01/2018 - 07/2010
2	AntibodiesIBA 11/2021 - 03/2021
2	Virulence Factors (Pathogenicity Factors)IBA 03/2021 - 09/2009
2	Doxycycline (Periostat)FDA LinkGeneric 01/2021 - 11/2020
2	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2021 - 11/2020
2	Angiotensin-Converting Enzyme 2IBA 01/2021 - 01/2021
2	Indicators and Reagents (Reagents)IBA 10/2020 - 05/2005
2	IronIBA 01/2019 - 01/2017
2	Lipoproteins (Lipoprotein)IBA 01/2019 - 09/2009
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016 - 04/2011
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2022
1	Bacterial RNAIBA 10/2021
1	RNA (Ribonucleic Acid)IBA 10/2021
1	EpitopesIBA 03/2021
1	CalciumIBA 03/2021
1	mRNA VaccinesIBA 01/2021
1	Lipid NanoparticlesIBA 01/2021
1	RicinIBA 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021
1	AgarIBA 01/2021
1	Subgenomic RNAIBA 01/2021
1	CollagenIBA 11/2020
1	Laminin (Merosin)IBA 11/2020
1	Metalloproteases (Metalloproteinases)IBA 11/2020
1	Contrast MediaIBA 12/2019
1	Twin-Arginine-Translocation SystemIBA 01/2019
1	AminoglycosidesIBA 01/2018
1	SuspensionsIBA 01/2018
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2015
1	Chemotactic FactorsIBA 05/2015
1	Messenger RNA (mRNA)IBA 05/2015
1	GoldIBA 05/2014
1	ORALIT (ORS)IBA 05/2014
1	Bronchodilator Agents (Bronchodilators)IBA 01/2014
1	N 30IBA 02/2012
1	CytokinesIBA 01/2012
1	ChemokinesIBA 01/2012
1	SteroidsIBA 04/2011
1	Attenuated VaccinesIBA 02/2004

Therapy/Procedure

10	Therapeutics 01/2022 - 09/2011
1	Phage Therapy 01/2022
1	Segmental Mastectomy (Lumpectomy) 12/2019
1	Neoadjuvant Therapy 12/2019
1	Mastectomy (Mammectomy) 12/2019
1	Biological Therapy 08/2009
1	Thyroidectomy 08/2009
1	Pneumonectomy (Lung Volume Reduction) 08/2004